Short Interest in ALK-Abelló A/S (OTCMKTS:AKBLF) Expands By 75.2%

ALK-Abelló A/S (OTCMKTS:AKBLF) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totaling 126,792 shares, a growth of 75.2% from the April 30th total of 72,390 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.

ALK-Abelló A/S Price Performance

OTCMKTS:AKBLF opened at $38.89 on Tuesday. The stock’s 50-day simple moving average is $34.55 and its 200 day simple moving average is $35.05. ALK-Abelló A/S has a twelve month low of $26.99 and a twelve month high of $38.89.

About ALK-Abelló A/S

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.